Great Ormond Street Hospital
London, WC1N 3JH, United Kingdom
NCT Number: NCT05571501
Walking measurement in children is important but there are challenges associated with obtaining reliable repeatable data in a clinical setting that is meaningful and easy to interpret. This study set out to develop a new way to collect, record, and interpret walking data that is suitable for the clinical environment. Developmental percentile charts were selected as they are widely recognised and easily interpreted.
Looking for future studies?
Notify Me10 month–18 year
All sexes
Interventional
Not applicable
London, WC1N 3JH, United Kingdom
The primary output of the main cohort of typically developing children is the developmental percentile charts.
These will be then used to present the clinical longitudinal data against a normal backdrop of developmental changes in children.
This has multiple clinical applications in many of the children assessed by physiotherapy at GOSH and more widely Nationally and internationally
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10-20 walking assessment using the GAITRite walkway
Other names: GAITRite
Time frame: For the duration of the study measured once for typically developing and at multiple clinic visits over 24 months for clinical groups
Continuous numeric data summarising walking performance and characteristics
Time frame: 30 to 60 mins to collect relevant data at a single time point, with an update to include additional admissions over 24months
surgical history (where relevant)
Great Ormond Street Hospital for Children NHS Foundation Trust
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07616193
Brain Damage, Chronic, Brain Diseases
Leuven, Vlaams-Brabant, Belgium
View Trial DetailsNCT07567053
Brain Damage, Chronic, Brain Diseases
Fort Worth, Texas, United States
View Trial DetailsNCT07486388
Typically Developing Children
Diepenbeek, Limburg, Belgium
View Trial Details